https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-09-01 / Anticancer Res 2024 Sep;44(9):3713-3724
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-09-01 / Anticancer Res 2024 Sep;44(9):3713-37242024-09-01 00:00:002024-09-01 00:00:00Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-20 / Cureus 2024 Jul;16(7):e64972
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-20 / Cureus 2024 Jul;16(7):e649722024-07-20 00:00:002024-07-20 00:00:00Combination of Radiation Therapy, Wim’s Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-03 / Int J Cancer 2024 Oct;155(8):1443-1454
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-03 / Int J Cancer 2024 Oct;155(8):1443-14542024-07-03 00:00:002024-07-03 00:00:00Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-3093
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-30932024-07-01 00:00:002024-07-01 00:00:00Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-05-28 / Ann Transl Med 2024 Aug;12(4):77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-05-28 / Ann Transl Med 2024 Aug;12(4):772024-05-28 00:00:002025-02-25 11:37:38Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-284
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-2842024-04-21 00:00:002024-04-21 00:00:00The future of cancer vaccines against colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-15 / Cell Rep Med 2024 May;5(5):101516
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-15 / Cell Rep Med 2024 May;5(5):1015162024-04-15 00:00:002025-09-04 16:58:25Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-09 / Med Oncol 2024 Apr;41(5):112
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-09 / Med Oncol 2024 Apr;41(5):1122024-04-09 00:00:002024-04-09 00:00:00Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-16 / Inflammation 2024 Mar;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-16 / Inflammation 2024 Mar;2024-03-16 00:00:002024-03-16 00:00:00An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-02-20 / Front Immunol 2024;15:1368103
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-02-20 / Front Immunol 2024;15:13681032024-02-20 00:00:002024-02-20 00:00:00Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial
